Volker Klaus Schulze (Volker K Schulze)

Years Active: 2020-2020
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Julien Lefranc, Volker Klaus Schulze, Roman Christian Hillig, Hans Briem, Florian Prinz, Anne Mengel, Tobias Heinrich, Jozsef Balint, Srinivasan Rengachari, Horst Irlbacher, Detlef Stöckigt, Ulf Bömer, Benjamin Bader, Stefan Nikolaus Gradl, Carl Friedrich Nising, Franz von Nussbaum, Dominik Mumberg, Daniel Panne, Antje Margret Wengner
Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor. Journal of medicinal chemistry 63 (2) (2020)
Volker Klaus Schulze, Ulrich Klar, Dirk Kosemund, Antje M Wengner, Gerhard Siemeister, Detlef Stöckigt, Roland Neuhaus, Philip Lienau, Benjamin Bader, Stefan Prechtl, Simon J Holton, Hans Briem, Tobias Marquardt, Hartmut Schirok, Rolf Jautelat, Rolf Bohlmann, Duy Nguyen, Amaury E Fernández-Montalván, Ulf Bömer, Uwe Eberspaecher, Michael Brüning, Olaf Döhr, Marian Raschke, Bertolt Kreft, Dominik Mumberg, Karl Ziegelbauer, Michael Brands, Franz von Nussbaum, Marcus Koppitz
Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 Kinase. Journal of medicinal chemistry 63 (15) (2020)

Volker Klaus Schulze.css-eqlu8i{font-size:small;padding-left:4px;} (Volker K Schulze)